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Abstract
Communicating with family members is critically important when a severely ill 
patient is experiencing their last few days of life. However, healthcare professionals 
(HCPs) have limited opportunities to learn effective and respectful ways to perform 
this communication. In recent decades, significant effort has been put forth to 
identify the phenomena that indicate the last hours and days of life and the optimal 
methods to deliver a death pronouncement, which will potentially help HCPs com-
municate compassionately with family members throughout the dying process. In this 
chapter, we will review the literature regarding the phenomena that indicate the last 
hours and days of life and the death pronouncement. Furthermore, we will discuss 
clinical implications derived from those articles and future research perspectives.
Keywords: communication, impending death, bereaving family,  
death pronouncement
1. Introduction
The death and dying of a loved one can place a serious emotional burden on his/
her family members [1]. The methods of communication during the dying process 
and the death pronouncement are critically important because they can affect the 
families’ acute emotional responses and their long-term psychological well-being 
[2]. However, there are limited opportunities to learn effective and respectful 
methods of how to communicate at the end of life and the pronouncement of a 
patient’s death even though healthcare professionals (HCPs) often experience such 
challenges in daily practice.
Over the last decade, cumulative evidence has revealed various phenomena 
that indicate the patient is experiencing their last hours and days of life (e.g., 
death rattle, cyanoses, or Cheyne-Stokes respiration) [3, 4]. Sharing these bedside 
clinical signs with families can allow them to understand the patients’ condition, 
estimate prognosis, and prepare for the impending event. Moreover, a recent unique 
research study regarding the death pronouncement (e.g., a video-vignette study 
design) revealed effective and respectful ways to deliver this pronouncement [5]. 
Palliative Care
2
The communication processes between HCPs and family members can potentially 
reduce the unpleasant emotional responses of the families.
In this chapter, we will review the reported literature regarding communication 
during the dying process and death pronouncement. Furthermore, we will discuss 
clinical implications derived from those articles and future research perspectives.
2. Phenomena indicating the last hours and days of life
As the time of death approaches, patients with advanced cancer follow various 
clinical courses and commonly experience serious burdens such as pain, dyspnea, 
or delirium [4, 6]. Previous literature has reported that patients and their family 
members hope to be free from physical and emotional distress at the end of life, and it 
is challenging for HCPs to assess the patients’ distress and deliver optimal care during 
end-of-life situations [7]. Understanding the bedside trajectory of the patients’ symp-
toms and distress will potentially allow HCPs to develop a reasonable end-of-life care 
pathway, which enables them to share the patient’s condition and promotes family 
members to prepare for the impending event [3, 8]. Actually, leaflet-based interven-
tions that describe physical impending death signs have been revealed to improve 
family members’ knowledge and distress throughout the dying process [9, 10].
We herein review the literature regarding representative and common phenom-
ena that indicate the last hours and days of life.
2.1 Common symptoms in the last weeks of life
During the last 2 weeks of life, dyspnea, pain, increased bronchial secretions, 
and confusion occur with prevalence of 56.7, 52.4, 51.4, and 50.1%, respectively 
[4]. As death approaches, the prevalence of dyspnea and confusion increases [8]. 
Meanwhile, pain was reported to reach a stable level of intensity [8]. Thus, HCPs 
must not underestimate those common symptoms and other hidden signs of 
distress and symptoms in patients.
Accordingly, performance status also deteriorates throughout the dying process 
[8, 11]. Because of muscle weakness and refractory cachexia, time spent in bed 
increases. Moreover, patients experience difficulties with performing daily activi-
ties such as changing clothes, bathing, swallowing, etc. At this point, because of 
the loss of autonomy, patients often feel emotionally and spiritually burdened, and 
supportive communication to cope with these distresses must be encouraged.
2.2 Common symptoms in the last days of life
In 2013, a Delphi method study including a panel of palliative care experts 
reached a consensus that the following seven clinical signs serve as impending death 
signs: changing breathing rhythm and patterns (e.g., Cheyne-Stokes respiration, 
apnea), irreversible deterioration of consciousness, no fluid or food intake, marble-
like skin, changing emotional status (e.g., restlessness, agitation), rapid degrada-
tion of general condition, and intuition of professionals (gut feeling) [12]. A unique 
longitudinal observational study revealed a detailed symptom trajectory in the 
last days of life [13]. In this study, apnea, Cheyne-Stokes respiration, increased 
bronchial secretions, dysphasia of liquids, a decreased level of consciousness, a 
palliative performance scale score ≤ 20%, peripheral cyanosis, pulselessness of the 
radial artery, respiration with mandibulae movement, and decreased urine output 
were recognized as impending death signs. Particularly, a palliative performance 
scale score ≤ 20%, decreased levels of consciousness, and dysphasia of liquids 
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commonly occur in the last 3 days of life. The authors suggested dividing impending 
death signs into two categories: early and late signs [13]. Early signs (e.g., decreased 
performance status, decreased oral intake, and decreased level of consciousness) 
are observed relatively frequently. Because of their low specificity, these signs are 
not reliable predictive markers of a death event within 3 days. By contrast, late 
signs emerge only in the last few days of life in a smaller proportion of patients and 
had a high positive likelihood ratio for impending death within 3 days. The author 
concluded that late physical signs may assist clinicians in making a diagnosis of 
impending death [13]. The same research groups reported an inability to close the 
eyelids, drooping of the nasolabial fold, hyperextension of the neck, and grunting 
of vocal cords as promising impending death signs [14].
2.3 Detailed discussion of common symptoms and clinical signs
2.3.1 Pain
Pain control is a common clinical challenge at any stage of disease [15]. Pain in 
the last 2 weeks of life and 48 hours before death occurs with a prevalence of 44 and 
54%, respectively [4, 7]. With inappropriate pain control, both patients and care-
givers are likely to complain of fatigue, anorexia, and insomnia [16].
Various agents have been investigated to relieve cancer pain and pathophysiolog-
ical assessments of pain (e.g., nociceptive, somatic, and visceral pain); therefore, 
selecting a reasonable treatment strategy is essential [17–21]. During the end-of-life 
stage, many patients suffer from swallowing difficulties, and in such cases, HCPs 
must consider alternative routes for administering analgesics to achieve appropriate 
pain control without interruption. Intravenous and subcutaneous administrations 
are stable, less invasive methods [22].
2.3.2 Dyspnea
Dyspnea results from several causes, including atelectasis due to tumor growth, 
pleural effusion, superior vena cava syndrome, pulmonary embolism, anemia, 
etc. [15, 23, 24]. The prevalence of dyspnea in the last 2 weeks of life is 56.7% [4]. 
Patient dyspnea is well known to be associated with family members’ distress [25].
The effect of morphine on alleviating dyspnea has been well investigated [26]. 
Because of the deteriorated capacity of drug metabolism and excretory abilities dur-
ing the end-of-life period, the administration of morphine requires careful monitor-
ing of adverse events (e.g., impaired conscious state and decreased respiration rate) 
[26]. Given the concerns of those adverse events, physicians are less confident with 
prescribing opioids for dyspnea than for pain, which can result in the undertreat-
ment of dyspnea [27]. Optimal clinical training is warranted in this setting. In addi-
tion, benzodiazepines can be a treatment option against refractory dyspnea [25].
In addition to pharmacological treatment, some non-pharmacological 
approaches are also promising for dyspnea. Recently, a unique study revealed that 
fan therapy toward the face is effective for patients with advanced lung cancer [28, 29]. 
Moreover, it is empirically known that changing body posture and discharging 
sputum are also effective methods of dyspnea care.
2.3.3 Increased bronchial secretions
With impending death, a rattle sound can be heard during both the inspira-
tory and expiratory phases around the upper respiratory tract area. Bennett 
divided this symptom into two subtypes: type I and II [30]. Type I is mainly 
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caused by the accumulation of salivary secretions due to a decrease in conscious-
ness and swallowing reflex [30]. Generally, anticholinergic drugs that suppress 
secretions from the salivary glands and endobronchial mucous are promising 
strategies to treat type I. Since type II is believed to be caused by purulent sputum 
such as tumor-derived secretions and pneumonia, anticholinergics are consid-
ered ineffective [30].
Classical anticholinergic drugs such as atropine, scopolamine hydrobromide, 
and glycopyrronium, which reduce secretions from the salivary glands and bron-
chial mucosa, are commonly used [31]. These medications can be administered 
sublingually, subcutaneously, and intravenously. Despite the cumulative experience 
of administering classical anticholinergic drugs among HCPs, there is a lack of suf-
ficient investigations on their effects. A double-blinded clinical trial from Germany 
showed the superior efficacy of glycopyrronium compared to scopolamine hydro-
bromide [32]. In a randomized controlled trial conducted in Belgium, the subcu-
taneous administration of atropine, scopolamine butylbromide, and scopolamine 
hydrobromide showed an improvement of approximately 40% on a pre-post basis; 
no significant difference between the drugs was reported [33]. Recently, the pro-
phylactic administration of hyoscine butylbromide was shown to effectively prevent 
the death rattle [34]. However, because a randomized controlled study found that 
atropine was not superior to a placebo control, anticholinergic drugs are not widely 
recognized as the gold standard treatment [35].
Since the rattle sound due to increased bronchial secretions may cause family 
members to anticipate patient distress, appropriate information sharing among 
family members and HCPs is crucial [36]. A survey for bereaved family members 
revealed that 66% felt distress due to the rattle sound and 53% reported the need to 
improve this symptom [36]. Conversely, another study found that the death rattle 
may not be associated with respiratory distress in coma patients [37]. In cases of 
refractory rattle sounds, HCPs must explain to family members that the patients 
are experiencing limited distress, and HCPs should continue care for their grief and 
suffering [37].
2.3.4 Delirium
Delirium at the terminal stage is occasionally described as agitation or terminal 
restlessness, which occurs as an irreversible symptom due to organ dysfunction 
[38]. Delirium occurred in 44% of patients during the last 7 days of life, and 88% of 
cancer patients with delirium had incurable end-stage delirium [38]. Delirium not 
only causes patients unbearable distress, but more than half (54%) of the family 
members reported distress as well [39].
To treat a patient’s delirium, the reversible causes must be examined and treated 
(e.g., infection, electrolyte abnormalities, nutritional deficiency, dehydration, and 
medications). The administration of olanzapine, quetiapine, and aripiprazole may 
provide some benefits for the patient [40]. Although a clinical study showed that 
neither oral haloperidol nor risperidone had a demonstrable benefit on the symp-
tomatic management of mild-to-moderate delirium, antipsychiatry drugs includ-
ing haloperidol and chlorpromazine are generally used for delirium in end-stage 
patients [41, 42]. Administering haloperidol with lorazepam may benefit terminal 
cancer patients (median overall survival of 73 hours) with agitated delirium [43]. 
Since these drugs can be administered intravenously, subcutaneously, or intramus-
cularly, suitable administration is possible even in end-of-life patients. However, 
since it may fail to show improvements despite appropriate treatment and care, 
delirium is one of the most common reasons for the decision to initiate sedative 
therapy (57.1%) [44].
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2.3.5 Vital signs
Vital signs include the level of consciousness, blood pressure, pulse rate, respira-
tory rate, O2 saturation, etc. [45]. Vital signs are indicators that can reflect several 
abnormal and altered states of human biological status [46]. These indicators can 
often be surrogate markers of distress such as pain or dyspnea, even in patients with 
loss of consciousness. However, vital signs may have a limited role as prognosis 
predictors. Previous literature has revealed that blood pressure and O2 saturation 
tend to decrease and body temperature tends to increase in the last 3 days of life, 
but their sensitivity and specificity to predict death within 3 days were 30 and 80%, 
respectively [45]. Thus, routine monitoring of vital signs may not be essential in 
end-of-life clinical practice.
2.3.6 Other clinical signs
Patients with Cheyne-Stokes respiration display abnormal respiration patterns 
that repeat cycles of apnea and a gradually increasing and decreasing respiratory rate 
[13]. During the last 3 days of life, 41% of patients experience this symptom [47].
Respiration with mandibulae movement is known as a late impending death 
sign. Patients unintentionally move their lower jaw up and down, commonly with 
loss of consciousness [13]. During the last 3 days of life, 56% of patients experience 
this symptom, which may predict death occurrence within 7.6 (±2.5) hours [48].
Cyanosis is caused by increased deoxyhemoglobin within the peripheral tis-
sue. Central cyanosis is commonly derived from shock status and congestive heart 
failure, whereas peripheral cyanosis commonly affects local lesions caused by 
peripheral vascular disease [13]. At the end of life, cyanosis is believed to be caused 
by contraction of the peripheral vessels. During the last 3 days of life, 56% of 
patients experience this symptom, which can predict death occurrence within 5.1 
(±1.0) hours [48].
2.3.7 Prognosis prediction
Prognosis prediction is also a critical issue in end-of-life care and is partially 
composed of the abovementioned symptoms and clinical signs. Several user-
friendly clinical tools have been developed in previous studies, such as the pallia-
tive prognostic score, the palliative prognostic index, and prognostic in palliative 
care study predictor models [49–51]. Detailed discussion regarding this topic is 
described elsewhere  [52].
3. Death pronouncement
When a patient dies, physicians must relay this information to his/her fam-
ily members. Generally, to diagnose the patient’s death, physicians examine the 
vanished pulse, respiratory cycles, and heart sounds [53]. This procedure is not only 
a clinical practice but is also a valuable opportunity for compassionate communica-
tion with his/her family members and can help alleviate their grief and emotional 
burden [53, 54]. Recent evidence has disclosed the optimal way to deliver a death 
pronouncement. However, the death pronouncement can be a considerably stress-
ful event even for physicians, which potentially leads to unfavorable outcomes such 
as insomnia, anxiety, or depression. Brown et al. revealed that the death pronounce-
ment can cause serious distress even in simulation settings [55]. Education for HCPs 
and healthcare students may play an essential role in coping with this distress. To 
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date, several educational activities regarding death pronouncement and procedure 
guides have been developed.
We herein review the previous literature regarding the optimal method of 
delivering the death pronouncement and education on this topic.
3.1 History of death pronouncement education
Initially, narrative guidelines for death pronouncements were proposed in the 
early 1990s. In 1992, Terri A. Schmidt et al. proposed a program that included 
17 recommendations on how to conduct interactions with survivors following a 
patient’s sudden death in the emergency department [56]. This program required 
2 1/2 hours to complete and allowed residents to practice their communication 
skills in a protected setting [56]. In the same year, the Office of Attorney General 
of Iowa proposed a recommended procedure for the death pronouncement called 
“in person, in time.” This recommendation conveyed the following five concepts: 
“in person” (respect for privacy and for free emotional reactions), “in time” 
(information should be delivered as soon as possible), “in pairs” (news should be 
delivered by a team of two notifiers), “in plain language” (the message should be 
relayed directly; the notifier ought to speak slowly and in single sentences, giving 
details and answering questions), and “with compassion” (empathy, the attempt to 
understand emotions accompanying individuals who are notified about the death of 
a close relative, is essential) [57]. In 1998, Lucille Marchand et al. introduced brief 
clinical tips for residents, which included six steps (the phone call, the patient floor, 
in the room, the pronouncement, documentation, and when to call the corner), to 
clarify how the death pronouncement process should proceed [58].
3.2 Educational intervention regarding the death pronouncement
In conjunction with those narrative approach efforts mentioned above, the effi-
cacy of the educational intervention was investigated. Marc et al. reported that one 
and a half lectures regarding the death pronouncement improved the skills of resi-
dent physicians who attended an ACLS course [59]. Lucille Marchand et al. reported 
on outcomes derived from a workshop based on six essential competencies (patient 
care, medical knowledge, practice-based learning and improvement, systems-based 
practice, professionalism, and interpersonal skills communication) proposed by the 
Accreditation Council for Graduate Medical Education’s Outcome Project [60]. This 
workshop provided the opportunities to learn poetry, prose, and narratives on deliv-
ering death pronouncements by senior residents; reviews and discussion of protocols 
for death pronouncement, autopsy, and organ donation; and a roleplay of a death 
pronouncement with the opportunity for reflection [60]. In 2005, Bailey et al. exam-
ined the effectiveness of a 10-minute death pronouncement module and pocket-card 
guideline approach [54]. This intervention improved five self-assessed competencies, 
including three procedure skills (clinical examination for pronouncing death, writing 
the death note, and completing the death certificate) and two communication skills 
(informing the family about the death and assessing/managing family bereave-
ment) [54]. In 2008, Hobgood et al. investigated the efficacy of a 2-hour teaching 
module based on the mnemonic “The GRIE_VING,” which included small group 
discussion, roleplay, and didactic experiences [61]. This module improved resident 
confidence and competency scores on a pre-post basis [61]. The authors also reported 
on the efficacy of this intervention in fourth-year medical students [62]. In 2011, 
Nordstrom et al. reported a unique approach employing a marathon death exercise. 
This exercise was designed to enable fourth-year medical students to gain insight 
into the emotional and formal procedure of delivering a death pronouncement [63]. 
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As mentioned above, a considerable number of studies that used lectures and/or 
roleplay for pre/post medical education showed promising efficacy.
3.3 Optimal method of delivering the death pronouncement
In addition to considering and discussing the optimal way to deliver a death pro-
nouncement among HCPs, it may be helpful to acquire opinions from viewpoints 
of family members, which potentially include definite answers. Kusakabe et al. 
performed a survey of bereaved family members [64]. The families experienced a 
death pronouncement in home care settings, and 89% reported that there were no 
deficiencies throughout the process [64]. Family members reported that positive 
physician behaviors included acting calmly (not rushed), having a suitable appear-
ance for the situation, introducing themselves to the family members, explaining 
the cause of death explicitly, and conducting a check using a light and stethoscope 
for the death pronouncement. Negative behaviors included a lack of clearly verify-
ing the time of death and leaving the patient’s clothes disheveled. Interestingly, 
Japanese family members did not appreciate touching the family members’ backs or 
shoulders as an expression of empathy [64]. Hatano et al. also conducted a survey of 
bereaved family members from hospice or palliative care unit settings [65]. Overall, 
86% of bereaved caregivers reported satisfaction with physician behavior toward 
the death pronouncement; however, 22% felt there were several areas requiring 
improvement. The bereaved caregivers did not appreciate automatic or routine 
pronouncement behaviors. Likewise, a logistic regression analysis revealed that 
“polite behavior” and the “physician introduced himself/herself to the family” 
were preferred behaviors. Confirmation by the primary responsible physician was 
significantly preferred than that by an unfamiliar physician [65]. Based on these 
findings of optimal behaviors, Mori et al. performed a unique study applying a 
randomized, scripted, video-vignette study design [5]. In this randomized, video-
vignette study, volunteer participants viewed two videos of death pronouncements 
by an on-call physician with or without compassion-enhanced behaviors [5]. This 
behavior included five components: “waiting until the families calm themselves 
down, explaining that the physician has received a sign-out containing information 
of the patient’s condition, performing the examination respectfully, ascertain-
ing the time of death with a wristwatch (vs. a smartphone), and reassuring the 
families that the patient did not experience pain.” Participants who viewed the 
compassion-enhanced behaviors video assigned significantly higher scores for 
physician compassion and trust in the physician and lower scores for anger, sadness, 
fear, and disgust. This study proposed recommendations that physicians should 
initiate a prompt examination, explain that they have received a sign-out, perform 
the examination respectfully, ascertain the time of death with a wristwatch, and 
reassure the families that the patient did not experience pain [5].
3.4 Future perspectives
As described above, several educational intervention models have been devel-
oped, and reasonable methods of delivering the death pronouncement have been 
proposed. However, one study suggested that only 35% of the procedures were 
judged as acceptable [66]. We must continue to grasp and improve the overall 
quality of the death pronouncement delivery by HCPs. Moreover, to determine the 
HCPs’ burden in this setting, a scale that measures the difficulties of delivering a 
death pronouncement must be developed.
The next steps must investigate whether those interventions or behaviors truly 
improve the outcomes of bereaved family members (e.g., depression, anxiety, or 
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substance abuse.) Accordingly, investigating the efficacy of alleviating the emo-
tional burden of HCPs is also necessary. Continuous efforts to develop effective 
educational interventions and implement practical models that can meet the needs 
of several medical contexts are also warranted.
4. Conclusions
In this chapter, we narratively reviewed various phenomena that indicate the 
impending last hours and days of life and the death pronouncement within a scien-
tific context. These findings can help enable HCPs to engage in compassionate com-
munication with the family members who share the same ultimate goals. Further 
efforts to integrate and enhance this knowledge and these activities are warranted 
to alleviate the burden and distress of patients, family members, and HCPs.
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